arsenic trioxide has been researched along with Anaplastic Astrocytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, KJ; Fisher, PG; Gibbs, IC; Gore, L; Hayashi, RJ; Macy, ME | 1 |
| Falnoga, I; Podgornik, H; Pucer, A; Slejkovec, Z; Tusek-Znidaric, M | 1 |
1 trial(s) available for arsenic trioxide and Anaplastic Astrocytoma
| Article | Year |
|---|---|
A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood.
Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Astrocytoma; Brain Stem Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Dose Fractionation, Radiation; Female; Follow-Up Studies; Humans; Male; Neoplasm Grading; Oxides; Prognosis; Survival Rate; Young Adult | 2013 |
1 other study(ies) available for arsenic trioxide and Anaplastic Astrocytoma
| Article | Year |
|---|---|
Arsenic metabolism in multiple myeloma and astrocytoma cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Astrocytoma; Biotransformation; Bone Marrow Cells; Cell Line, Tumor; Chromatography, Ion Exchange; Humans; Models, Chemical; Multiple Myeloma; Oxides; Reactive Oxygen Species; Time Factors | 2007 |